IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD

Completed · Not applicable

Conditions studied: GVHD, Ocular Rosacea, Dry Eye Syndrome

In brief

The purpose of this study was to see if Intense Pulsed Light (IPL) can be used safely and effectively to help treat dry eyes from ocular rosacea after chronic graft-versus-host disease (GVHD). Current treatment options for this disease are limited.

Key facts

Study ID

NCT02066051

Run by

Mayo Clinic

People needed

8

Starts

2013-10-01

Expected to finish

2014-11-01

Last updated by the study team

2015-11-25

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ocular rosacea with inactive GVHD

You may not qualify if…

• Active GVHD
• Facial laser treatment
• Accutane exposure
• Inability to wear sun protection factor (SPF) 30 sunscreen and avoid sun exposure
• Inability to meet study requirements

Where it is running

• Mayo Clinic Arizona — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.